Thomas Pfisterer
Directeur/Bestuurslid bij ADC THERAPEUTICS SA
Vermogen: 34 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Thomas Pfisterer
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 28 | |
InSphero AG
 InSphero AG BiotechnologyHealth Technology InSphero AG supplies organotypic 3D microtissues for efficiency testing and toxicology in drug development. It offers 3D insight Islet, 3D InSight Tumor, Gravity TRAP ULA Plates, Cytotoxicity Assay Kit, 3D InSight in Vitro Toxixology services, imaging and automation. he company was founded by Jan Lichtenberg, Jens M. Kelm, Simon P. Hoerstrup and Wolfgang Moritz on March 26, 2009 and is headquartered in Schlieren, Switzerland.
9
| Holding Company | Biotechnology | 9 |
ImVax, Inc.
 ImVax, Inc. BiotechnologyHealth Technology ImVax, Inc. provides healthcare services. The company was founded in 2015 and is headquartered in Philadelphia, PA.
8
| Holding Company | Biotechnology | 8 |
Sermonix Pharmaceuticals LLC
 Sermonix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sermonix Pharmaceuticals LLC operates as a pharmaceutical company that focuses on the development and commercialization of late-stage women?s health products. It offers lasofoxifene, a selective estrogen receptor modulator for the treatment of vulvovaginal atrophy, as well as treatment and prevention of post-menopausal osteoporosis. The company was founded in 2014 by David Portman and is headquartered in Columbus, OH.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Lakewood-Amedex, Inc.
 Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Lakewood-Amedex, Inc. engages in the development of treatment for serious infectious diseases. Its product pipeline include Nu-3 cDFU, Nu-3 Oral Mucositis, Nu-8 cUTI, and Nu-8 (Cystic Fibrosis). The company is headquartered in Sarasota, FL.
6
| Private Company | Pharmaceuticals: Major | 6 |
Bloom Diagnostics AG
 Bloom Diagnostics AG Packaged SoftwareTechnology Services Bloom Diagnostics AG engages in the provision of diagnostics platform through medical knowledge, computer science, biotechnology, and data analytics. The company was founded by Angelica Kohlmann and Tom Kupper and is headquartered in Zurich, Switzerland.
5
| Holding Company | Packaged Software | 5 |
WILD Flavors GmbH
 WILD Flavors GmbH Food: Specialty/CandyConsumer Non-Durables WILD Flavors GmbH operates as a holding company with interests in flavoring extracts, food coloring and similar products. It supplies natural flavors, colors, and ingredients to the food and beverage industry. WILD Flavors product portfolio of natural flavor ingredients and solutions for the food and beverage includes components such as natural flavors and extracts, natural colors, concentrates, sweetening systems, specialty ingredients and seasonings, as well as functional flavors and healthy ingredients, taste modifiers, and fermentation technologies. The company is headquartered in Zug, Switzerland.
2
| Extinct | Food: Specialty/Candy | 2 |
Stade Français Paris SA
 Stade Français Paris SA Movies/EntertainmentConsumer Services Stade Français Paris SA owns and operates rugby union club. It offers rugby training for professionals, non-professionals, and children. The company was founded in in May 1995 and is headquartered in Paris, France.
2
| Private Company | Movies/Entertainment | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thomas Pfisterer via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| CELGENE | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Comptroller/Controller/Auditor Chief Operating Officer Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Founder Director of Finance/CFO Chief Operating Officer | |
ADC Therapeutics (UK) Ltd.
 ADC Therapeutics (UK) Ltd. BiotechnologyHealth Technology Part of ADC Therapeutics SA, ADC Therapeutics (UK) Ltd. is a British company that provides research and experimental development in biotechnology. The company is based in Reading, UK and was founded in 2014. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Auven Therapeutics Management LLLP
 Auven Therapeutics Management LLLP Investment ManagersFinance Founded in 2007 by Stephen Evans-Freke and Peter Corr, Auven Therapeutics Management LLLP is a global private equity firm located in St. Thomas, Virgin Islands. They also have operations in New York City and Europe. The firm was formerly known as Celtic Therapeutics Management, which was the successor firm to Celtic Pharma Management LP. | Investment Managers | Founder Founder Private Equity Investor | |
ADC Products (UK) Ltd.
 ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom. | Medical/Nursing Services | Founder Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Human Resources Officer | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
Sprout Pharmaceuticals, Inc.
 Sprout Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sprout Pharmaceuticals, Inc. provides delivery of a treatment option for the unmet need of women with Hypoactive Sexual Desire Disorder. The company was founded by Cynthia E. Whitehead and Robert S. Whitehead on November 29, 2011 and is headquartered in Raleigh, NC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| The University of Chicago | College/University | Graduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| SMITH & NEPHEW PLC | Medical Specialties | Director/Board Member Director/Board Member | |
| Kohlmann & Co. Ag | Chairman Founder | ||
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
| IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| University of East Anglia | College/University | Doctorate Degree Undergraduate Degree | |
Auven Therapeutics Holdings LP
 Auven Therapeutics Holdings LP Investment ManagersFinance Auven Therapeutics Holdings LP invests in late stage companies developing therapeutic products (small-molecules & biologics) and related diagnostics. It provides financing for buyouts and late stage capital requirements. It makes controlling investments. | Investment Managers | Founder Chief Executive Officer | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA. | Biotechnology | Director of Finance/CFO Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Spirogen SARL
 Spirogen SARL Pharmaceuticals: MajorHealth Technology Spirogen SARL is a Swiss company. 'The private company is based in Lausanne, Switzerland. The company was founded by Christopher John Martin. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Badertscher Rechtsanwälte AG
 Badertscher Rechtsanwälte AG Miscellaneous Commercial ServicesCommercial Services Badertscher Rechtsanwälte AG is a national and internationally recognized law firm specializing in business, tax, and notary law, with offices in Zurich and Zug, Switzerland. The firm provides legal services to Swiss and foreign companies, public institutions, and individuals. The team of two dozen lawyers offers comprehensive legal advice in private and public law. The firm's approach is holistic, efficient, and solution-oriented, with a focus on tailored solutions that meet clients' needs. The firm's areas of expertise include insurance and liability law, corporate law, and public law. The firm also offers career opportunities for lawyers interested in joining their team. | Miscellaneous Commercial Services | Corporate Officer/Principal President | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Georgetown University | College/University | Corporate Officer/Principal Masters Business Admin | |
Cibus US LLC
 Cibus US LLC BiotechnologyHealth Technology Cibus Genetics LLC is a biotechnology company. It develops products in agriculture and specialty chemicals. The company was founded by Peter Beetham in 2001 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Chairman | |
WILD Flavors, Inc.
 WILD Flavors, Inc. Food RetailRetail Trade WILD Flavors, Inc. provides flavors, colors and ingredients, and taste modification systems and solutions to the food and beverage industry. It also offers packaging and processing food solutions. The company was founded in 1931 and is located in Erlanger, Kentucky. | Food Retail | Corporate Officer/Principal President | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Zurich | College/University | Doctorate Degree Corporate Officer/Principal | |
| Perelman School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Synergie Lyon Cancer
 Synergie Lyon Cancer Miscellaneous Commercial ServicesCommercial Services Synergie Lyon Cancer provides health care services. It focuses on research efforts on cancer escape, apoptosis and senescence and Immune surveillance. The company was founded in 2007 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | President | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
| Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal | ||
| MERUS N.V. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 33 |
| Verenigd Koninkrijk | 7 |
| Zwitserland | 7 |
| Ierland | 2 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 31 |
| Consumer Services | 10 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 289 |
| Corporate Officer/Principal | 147 |
| Independent Dir/Board Member | 89 |
| Chairman | 80 |
| Chief Executive Officer | 42 |
Sterkste connecties
| Insiders | |
|---|---|
| Thomas M. Rinderknecht | 34 |
| Stephen Evans-Freke | 34 |
| Wendy DiCicco | 30 |
| Michael Friedman | 30 |
| Peter Corr | 28 |
| Steven Altschuler | 27 |
| Richard de Schutter | 24 |
| Jean Bizzari | 24 |
| Stephen Webster | 23 |
| Viviane Monges | 22 |
| Tony H. Wild | 22 |
| Jacques Theurillat | 22 |
| Geoffrey F. Cox | 20 |
| Christopher Martin | 18 |
| Michael Forer | 18 |
- Beurs
- Insiders
- Thomas Pfisterer
- Bedrijfsconnecties
